#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Drug eruption Autoimmune hepatitis Pulmonary tuberculosis Plasma cell myeloma recurrent Neonatal alloimmune thrombocytopenia Cholestatic pruritus Dementia Necrotising enterocolitis neonatal Adenocarcinoma gastric Non-small cell lung cancer metastatic Ataxia telangiectasia High-grade B-cell lymphoma Mantle cell lymphoma refractory Hypocalcaemia Von Willebrand's disease More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Diagnostics Chondrosarcoma – Diagnostics Alport’s syndrome – Basic Information Pulmonary sarcoidosis – Diagnostics Sjogren’s syndrome – Life with Disease Cholangitis sclerosing – Diagnostics Piriformis syndrome Paroxysmal nocturnal haemoglobinuria – Diagnostics Breast angiosarcoma – Life with Disease Hereditary hypophosphataemic rickets – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tozorakimab POTASSIUM HYDROXIDE Sasanlimab Masupirdine GSKVX000000034797 GSKVX000000034796 Acp-017 Clascoterone GSKVX000000034798 Benralizumab Lactose Nofazinlimab Tucidinostat Reparixin Sodium Iodide (123 I) H2-Receptor Antagonist GSKVX000000070965 Sorafenib GSKVX000000048110 Nms-03305293 More therapies…

    Learn about Your Condition

    Juvenile idiopathic arthritis Inflammation Metastasis Colitis Cerebral amyloid angiopathy Adrenocortical carcinoma Vaginal haemorrhage Vascular graft thrombosis Urticaria cholinergic Shock Lipid metabolism disorder Graft versus host disease Laryngeal cancer stage II Eructation Pyrexia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Estonia

  • Study on the Effects of Tildacerfont and Hydrocortisone in Adults with Classic Congenital Adrenal Hyperplasia

    Not recruiting

    2 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Tildacerfont
    • Hydrocortisone
    Denmark Estonia Germany Ireland Italy Latvia +6
  • Study on Tildacerfont to Reduce Glucocorticoid Use in Adults with Classic Congenital Adrenal Hyperplasia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Tildacerfont
    • Hydrocortisone
    • Prednisolone
    Denmark Estonia Germany Ireland Italy Latvia +6
  • Study on the Effects of Atacicept in Adults with IgA Nephropathy

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Atacicept
    • Enalapril
    • Losartan
    Belgium Croatia Czechia Denmark Estonia France +7
  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9
  • Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Darolutamide
    Belgium Bulgaria Czechia Estonia Finland France +11
  • Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cisplatin
    • Fluorouracil
    • Gemcitabine Hydrochloride
    Czechia Estonia France Hungary Italy Latvia +5
Previous Page
1 … 26 27 28 29 30 … 32
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cisplatin Dexamethasone Fluorouracil Durvalumab Hydrocortisone Prednisolone Oxaliplatin Risankizumab Cytarabine Venetoclax Etoposide Olaparib Upadacitinib Prednisone Carboplatin Tocilizumab Mycophenolate Mofetil Milvexian Pneumococcal Polysaccharide Serotype 15B Pneumococcal Polysaccharide Serotype 7F Efgartigimod Alfa Pneumococcal Polysaccharide Serotype 18C Pneumococcal Polysaccharide Serotype 8 Atorvastatin Pneumococcal Polysaccharide Serotype 19A Pneumococcal Polysaccharide Serotype 9N Pneumococcal Polysaccharide Serotype 19F Pneumococcal Polysaccharide Serotype 9V Empasiprubart Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acromegaly Acute coronary syndrome Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Adenocarcinoma gastric Adenocarcinoma of colon Adrenogenital syndrome Age-related macular degeneration Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis Bladder cancer Cardiac failure Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Coagulation factor X level Colitis ulcerative Colorectal cancer metastatic Colorectal cancer stage IV Coronary artery disease Critical illness Crohn's disease Cytomegalovirus immunisation Dementia Alzheimer's type Dermatitis atopic Diabetic foot infection Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Dyslipidaemia Emphysema Encephalopathy neonatal Endocrine ophthalmopathy Endometrial cancer Factor IX deficiency Factor VIII deficiency Focal segmental glomerulosclerosis Follicular lymphoma Gastric cancer Generalised anxiety disorder Genital herpes simplex Glioblastoma multiforme Hepatocellular carcinoma Herpes simplex Herpes zoster Hormone-refractory prostate cancer Hypercholesterolaemia Idiopathic pulmonary fibrosis IgA nephropathy Influenza Influenza immunisation Interstitial lung disease Lupus nephritis Macular oedema Major depression Mantle cell lymphoma Metapneumovirus infection Metastatic malignant melanoma Microsatellite instability cancer Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Neonatal asphyxia Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephropathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Obesity Oesophageal adenocarcinoma Oesophageal carcinoma Orthostatic hypotension Osteoarthritis Osteoporosis postmenopausal Overweight Paroxysmal nocturnal haemoglobinuria PD-L1 positive cancer Plasma cell myeloma Plasma cell myeloma refractory Pneumococcal immunisation Pneumonia Pneumonia respiratory syncytial viral Primary biliary cholangitis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer recurrent Psoriasis Psoriatic arthropathy Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal disorder Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Retinal vein occlusion Rheumatoid arthritis Richter's syndrome Secondary progressive multiple sclerosis Short-bowel syndrome Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Systemic lupus erythematosus Systemic scleroderma Thrombosis prophylaxis Type 1 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!